Washington Capital Management’s Halozyme HALO Stock Holding History

Washington Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,300	Closed	-$466K	–	119
2025 Q1	$466K	Hold	7,300	–	–	0.38%	79
2024 Q4	$349K	Hold	7,300	–	–	0.28%	97
2024 Q3	$418K	Sell	7,300 -3,500	-32%	-$201K	0.32%	92
2024 Q2	$565K	Sell	10,800 -4,700	-30%	-$206K	0.48%	66
2024 Q1	$631K	Hold	15,500	–	–	0.51%	56
2023 Q4	$573K	Hold	15,500	–	–	0.49%	65
2023 Q3	$592K	Hold	15,500	–	–	0.54%	48
2023 Q2	$559K	Hold	15,500	–	–	0.48%	64
2023 Q1	$592K	Buy	15,500 +3,000	+24%	+$141K	0.53%	50
2022 Q4	$711K	Hold	12,500	–	–	0.66%	37
2022 Q3	$494K	Hold	12,500	–	–	0.5%	65
2022 Q2	$550K	Sell	12,500 -5,200	-29%	-$225K	0.53%	52
2022 Q1	$706K	Buy	17,700 +1,100	+7%	+$39.2K	0.58%	43
2021 Q4	$667K	Buy	+16,600	New	+$620K	0.54%	52

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Washington Capital Management's HALO Position: Q2 2025 in Review

Washington Capital Management sold out of Halozyme (HALO) in Q2 2025, closing a stake of 7,300 shares — an estimated $466K sold.

Washington Capital Management first reported a position in HALO in Q4 2021 and held it in 14 quarters. The position peaked at $711K in Q4 2022. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

Washington Capital Management reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
Washington Capital Management sold 7,300 Halozyme shares in Q2 2025, an estimated $466K.
Washington Capital Management first reported a position in Halozyme in Q4 2021 and held it in 14 quarters.
Washington Capital Management's Halozyme position peaked at $711K in Q4 2022.
551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Washington Capital Management's 13F filing for Q2 2025, filed 17 Jul 2025.